Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 18 Similar Profiles
Biosimilar Pharmaceuticals
Medicine & Life Sciences
Nursing
Medicine & Life Sciences
Chemotherapy-Induced Febrile Neutropenia
Medicine & Life Sciences
Anemia
Medicine & Life Sciences
Geriatric Psychiatry
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Nurses
Medicine & Life Sciences
Nursing Homes
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1985 1992
- 2 Finished
NURSING TREATMENTS FOR DEPRESSED AGED IN LONG TERM CARE
3/1/87 → 2/28/89
Project: Research project › Research Project
BIOMEDICAL RESEARCH SUPPORT GRANT
Abraham, I. L., Morrision, E., Kiley, M., Krowchuk, H., Youngblut, J., Workman, L., Roberts, B. & Fitzpatrick, J.
4/1/85 → 9/29/92
Project: Research project › Biomedical Research Support Grants
Nursing Research
Health
Research
Cardiac Rehabilitation
Research Output 1982 2018
A single-arm, retrospective analysis of the incidence of febrile neutropenia using same-day versus next-day pegfilgrastim in patients with gastrointestinal cancers treated with FOLFOX or FOLFIRI
Eckstrom, J., Bartels, T., Abraham, I., Patel, H., Elquza, E., Scott, A. J., Malangone, S., Hollings, J. & McBride, A., Jan 1 2018, (Accepted/In press) In : Supportive Care in Cancer.Research output: Contribution to journal › Article
Febrile Neutropenia
Gastrointestinal Neoplasms
Incidence
Neutropenia
International Classification of Diseases
Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: Meta-analysis and risk/benefit assessment
Al Yami, M. S., Kurdi, S. & Abraham, I., Feb 21 2018, In : Journal of Blood Medicine. 9, p. 25-34 10 p.Research output: Contribution to journal › Article
Anticoagulants
Meta-Analysis
Venous Thromboembolism
Safety
Hemorrhage
Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer
Gharaibeh, M., McBride, A., Alberts, D. S., Erstad, B., Slack, M., Alsaid, N., Bootman, J. L. & Abraham, I., Jul 6 2018, (Accepted/In press) In : PharmacoEconomics. p. 1-11 11 p.Research output: Contribution to journal › Article
gemcitabine
Pancreatic Neoplasms
Cost-Benefit Analysis
Drug Therapy
Therapeutics
Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer
Gharaibeh, M., McBride, A., Alberts, D. S., Slack, M., Erstad, B., Alsaid, N., Bootman, J. L. & Abraham, I., Jun 9 2018, (Accepted/In press) In : PharmacoEconomics. p. 1-12 12 p.Research output: Contribution to journal › Article
gemcitabine
Pancreatic Neoplasms
Cost-Benefit Analysis
Drug Therapy
Quality-Adjusted Life Years
1
Citations
Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence
Bernstein, J. A., Kavati, A., Tharp, M. D., Ortiz, B., MacDonald, K., Denhaerynck, K. & Abraham, I., Apr 3 2018, In : Expert Opinion on Biological Therapy. 18, 4, p. 425-448 24 p.Research output: Contribution to journal › Review article
Urticaria
Quality of Life
Antibodies, Monoclonal, Humanized
Therapeutics
Safety